Overall, 7.4 percent of adults aged 85 years and older reported no chronic conditions, 37.3 percent reported four or more
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide